Drug intelligence / Profile preview

fentanyl (transdermal patch + oral transmucosal lozenge)

Development stage
Phase 4
Lead developer
Johnson & Johnson
Modality
Small Molecules
Administration
Transdermal, Oral Transmucosal
01

Overview

Fentanyl (transdermal patch + oral transmucosal lozenge) is a combination of two pharmaceutical formulations of the potent synthetic opioid analgesic fentanyl. The transdermal patch delivers a continuous dose of fentanyl through the skin for up to 72 hours and is primarily used for managing severe chronic pain in opioid-tolerant patients. The oral transmucosal lozenge ("lollipop") provides rapid-onset pain relief by allowing absorption through the buccal mucosa and is typically indicated for breakthrough cancer pain in opioid-tolerant individuals. Fentanyl acts as a full agonist at the mu-opioid receptor, producing analgesia and euphoria but also carrying significant risks including respiratory depression and potential for abuse or overdose[1][3][4][8].

Brand names
DuragesicActiq
Other names
fentanyl patchfentanyl lozengefentanyl lollipoptransdermal fentanyl systemoral transmucosal fentanyl citrate
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on fentanyl (transdermal patch + oral transmucosal lozenge).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fentanyl (transdermal patch + oral transmucosal lozenge).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call